Emmanuel Simonot

Emmanuel Simonot is a seasoned executive in the biotechnology and pharmaceuticals sectors, currently serving as the Head of Global Sales and Partnerships at OTR3, a leader in Matrix Therapy. With extensive experience in market access across various therapeutic areas including Neurology, Rare Diseases, Gene Therapy, and Oncology, Simonot has held significant roles, such as Pharmaceuticals General Manager and Commercial Operations Executive Senior Consultant at 80 Hg Consulting SAS. Previous positions include Head of Commercial Pharmaceuticals Services at Augur Associates and Global Partnerships Director at Medday Pharmaceuticals, where a focus on innovative treatment solutions for neurological conditions was emphasized. Simonot's career also encompasses pivotal roles in marketing and sales, notably at Orphan Europe, Kemin Industries, and Teva Pharmaceuticals. Emmanuel Simonot holds degrees in Medicine from the University of Medicine in Dijon and in Political Economy from Lycée Carnot.